Long-Term Follow-Up Of Hbsag Clearance In Patients With Hbeag-Negative Chb Treated With Peginterferon Alfa-2a: Increase In Hbsag, Clearance Rate From 3% 6 Months Post-Treatment To 8% After 3 Years
HEPATOLOGY（2007）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要